TCRT ▲ +36.2% - Alaunos Therapeutics, Inc.
$TCRT - Alaunos Therapeutics, Inc. Announces Pricing of Registered Direct Offering priced at-the-market under Nasdaq rules
Alaunos Therapeutics shares rose 36.2% following the company's announcement of a registered direct offering priced at-the-market under Nasdaq rules. The at-the-market offering structure, which allows the company to raise capital without a fixed discount, may have signaled confidence to investors and reduced dilution concerns compared to traditional discounted offerings.
18-SEP-2026 09:00 AM ET
Share this post
More filings for $TCRT
TCRT ▲ +57.7% - Alaunos Therapeutics, Inc.Sep 17, 2026TCRT ▲ +59.2% - Alaunos Therapeutics, Inc.Sep 17, 2026TCRT ▲ +59.2% - Alaunos Therapeutics, Inc.Sep 17, 2026TCRT ▲ +59.2% - Alaunos Therapeutics, Inc.Sep 17, 2026
View full $TCRT filing history →💬 Comments
Loading comments…
Leave a comment
